Gut permeability, its interaction with gut microflora and effects on metabolic health are mediated by the lymphatics system, liver and bile acid

References

• 1 Hill JO. Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocr. Rev. 27(7), 750–761 (2006).Crossref, Medline, Google Scholar
• 2 Dehghan M, Akhtar-Danesh N, Merchant AT. Childhood obesity, prevalence and prevention. Nutrition J. 4, 24 (2005).Crossref, Medline, Google Scholar
• 3 Bücker R, Troeger H, Kleer J, Fromm M, Schulzke J-D. Arcobacter butzleri induces barrier dysfunction in intestinal HT-29/B6 Cells. J. Infect. Dis. 200(5), 756–764 (2009).Crossref, Medline, CAS, Google Scholar
• 4 Arumugam M, Raes J, Pelletier E et al. Enterotypes of the human gut microbiome. Nature 473(7346), 174–180 (2011).Crossref, Medline, CAS, Google Scholar
• 5 Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat. Rev. Immunol. 10(10), 735–744 (2010).Crossref, Medline, CAS, Google Scholar
• 6 Wu HJ, Wu E. The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes 3(1), 4–14 (2012).Crossref, Medline, Google Scholar
• 7 Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nature Rev. Immunol. 9(5), 313–323 (2009).Crossref, Medline, CAS, Google Scholar
• 8 Cenit MC, Matzaraki V, Tigchelaar EF, Zhernakova A. Rapidly expanding knowledge on the role of the gut microbiome in health and disease. Biochim. Biophys. Acta 1842(10), 1981–1992 (2014).Crossref, Medline, CAS, Google Scholar
• 9 Frick JS, Autenrieth IB. The gut microflora and its variety of roles in health and disease. Curr. Topics Microbiol. Immunol. 358, 273–289 (2013).Medline, CAS, Google Scholar
• 10 Wellen KE, Hotamisligil GKS. Inflammation, stress, and diabetes. J. Clin. Invest. 115(5), 1111–1119 (2005).Crossref, Medline, CAS, Google Scholar
• 11 Heyman M, Abed J, Lebreton C, Cerf-Bensussan N. Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis. Gut 61(9), 1355–1364 (2012).Crossref, Medline, CAS, Google Scholar
• 12 Watts T, Berti I, Sapone A et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of Type I diabetes in BB diabetic-prone rats. Proc. Natl Acad. Sci. USA 102(8), 2916–2921 (2005).Crossref, Medline, CAS, Google Scholar
• 13 Teixeira TF, Collado MC, Ferreira CL, Bressan J, Peluzio Mdo C. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr. Res. 32(9), 637–647 (2012).Crossref, Medline, CAS, Google Scholar
• 14 Brignardello J, Brignardello J, Morales P, Diaz E, Romero J. Pilot study: alterations of intestinal microbiota in obese humans are not associated with colonic inflammation or disturbances of barrier function. Aliment. Pharmacol. Ther. 32(11–12), 1307–1314 (2010).Crossref, Medline, CAS, Google Scholar
• 15 Raybould HE. Gut microbiota, epithelial function and derangements in obesity. J. Physiol. 590(Pt 3), 441–446 (2012).Crossref, Medline, CAS, Google Scholar
• 16 Kerr C, Grice D, Tran C et al. Early life events influence whole-of-life metabolic health via gut microflora and gut permeability. Crit. Rev. Microbiol.(2013) (In press).Google Scholar
• 17 Turner HL, Turner JR. Good fences make good neighbors: gastrointestinal mucosal structure. Gut Microbes 1(1), 22–29 (2010).Crossref, Medline, Google Scholar
• 18 Ottman NA, Smidt H, Vos WM, Belzer C. The function of our microbiota: who is out there and what do they do? Front Cell Infect. Microbiol. 2, 104 (2012).Crossref, Google Scholar
• 19 Bischoff S. ‘Gut health’: a new objective in medicine? BMC Med. 9(1), 24 (2011).Crossref, Medline, Google Scholar
• 20 Lee AS, Gibson DL, Zhang Y, Sham HP, Vallance BA, Dutz JP. Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia 53(4), 741–748 (2010).Crossref, Medline, CAS, Google Scholar
• 21 Anderson JM, Van Itallie CM. Physiology and function of the tight junction. Cold Spring Harb Perspect. Biol. 1(2), a002584 (2009).Crossref, Medline, Google Scholar
• 22 Angelow S, Yu AS. Claudins and paracellular transport: an update. Curr. Opin. Nephrol. Hypertens. 16(5), 459–464 (2007).Crossref, Medline, CAS, Google Scholar
• 23 Di Pierro M, Lu R, Uzzau S et al. Zonula occludens toxin structure-function analysis: identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. J. Biol. Chem. 276(22), 19160–19165 (2001).Crossref, Medline, CAS, Google Scholar
• 24 Wang W, Uzzau S, Goldblum S, Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J. Cell Sci. 113(24), 4435–4440 (2000).Crossref, Medline, CAS, Google Scholar
• 25 Fasano A. Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer. Physiol. Rev. 91(1), 151–175 (2011).Crossref, Medline, CAS, Google Scholar
• 26 Sapone A, De Magistris L, Pietzak M et al. Zonulin upregulation is associated with increased gut permeability in subjects with Type 1 diabetes and their relatives. Diabetes 55(5), 1443–1449 (2006).Crossref, Medline, CAS, Google Scholar
• 27 Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 292(5519), 1115–1118 (2001).Crossref, Medline, CAS, Google Scholar
• 28 Di Mauro A, Neu J, Riezzo G et al. Gastrointestinal function development and microbiota. Ital. J. Pediatr. 39(1), 15 (2013).Crossref, Medline, Google Scholar
• 29 Kwak Y-K, Vikström E, Magnusson K-E, Vécsey-Semjén B, Colque-Navarro P, Möllby R. The Staphylococcus aureus alpha-toxin perturbs the barrier function in Caco-2 epithelial cell monolayers by altering junctional integrity. Infect. Immun. 80(5), 1670–1680 (2012).Crossref, Medline, CAS, Google Scholar
• 30 Sears CL, Kaper JB. Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion. Microbiol. Rev. 60(1), 167–215 (1996).Crossref, Medline, CAS, Google Scholar
• 31 Sawasvirojwong S, Srimanote P, Chatsudthipong V, Muanprasat C. An adult mouse model of induced diarrhea for studying pathogenesis and potential therapy of cholera. PLoS Negl. Trop. Dis. 7(6), e2293 (2013).Crossref, Medline, Google Scholar
• 32 Baudry B, Fasano A, Ketley J, Kaper JB. Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae. Infect. Immun. 60(2), 428–434 (1992).Crossref, Medline, CAS, Google Scholar
• 33 Mel SF, Fullner KJ, Wimer-Mackin S, Lencer WI, Mekalanos JJ. Association of protease activity in Vibrio cholerae vaccine strains with decreases in transcellular epithelial resistance of polarized T84 intestinal epithelial cells. Infect. Immun. 68(11), 6487–6492 (2000).Crossref, Medline, CAS, Google Scholar
• 34 Wu Z, Nybom P, Magnusson K-E. Distinct effects of Vibrio cholerae haemagglutinin/protease on the structure and localization of the tight junction-associated proteins occludin and ZO-1. Cell. Microbiol. 2(1), 11–17 (2000).Crossref, Medline, CAS, Google Scholar
• 35 Fasano A, Baudry B, Pumplin DW et al. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc. Natl Acad. Sci. USA 88(12), 5242–5246 (1991).Crossref, Medline, CAS, Google Scholar
• 36 Shifflett DE, Donnie ES, Daniel RC, Athanasia K, Jerrold RT. Enteropathogenic E. coli disrupts tight junction barrier function and structure in vivo. Lab. Invest. 85(10), 1308–1324 (2005).Crossref, Medline, CAS, Google Scholar
• 37 Dean P, Kenny B. Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein. Mol. Microbiol. 54(3), 665–675 (2004).Crossref, Medline, CAS, Google Scholar
• 38 Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell. Mol. Life Sci. 70(4), 631–659 (2013).Crossref, Medline, CAS, Google Scholar
• 39 Philpott DJ, Mckay DM, Mak W, Perdue MH, Sherman PM. Signal transduction pathways involved in enterohemorrhagic escherichia coli-induced alterations in T84 epithelial permeability. Infect. Immun. 66(4), 1680–1687 (1998).Crossref, Medline, CAS, Google Scholar
• 40 Brynestad S, Granum PE. Clostridium perfringens and foodborne infections. Int. J. Food Microbiol. 74(3), 195–202 (2002).Crossref, Medline, Google Scholar
• 41 Takahashi A, Kondoh M, Masuyama A et al. Role of C-terminal regions of the C-terminal fragment of Clostridium perfringens enterotoxin in its interaction with claudin-4. J. Control. Release 108(1), 56–62 (2005).Crossref, Medline, CAS, Google Scholar
• 42 Jepson MA, Schlecht HB, Collares-Buzato CB. Localization of dysfunctional tight junctions in Salmonella enterica serovar typhimurium-infected epithelial layers. Infect. Immun. 68(12), 7202–7208 (2000).Crossref, Medline, CAS, Google Scholar
• 43 Richter JF, Gitter AH, Günzel D et al. Listeriolysin O affects barrier function and induces chloride secretion in HT-29/B6 colon epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 296(6), G1350–G1359 (2009).Crossref, Medline, CAS, Google Scholar
• 44 Dickman KG, Hempson SJ, Anderson J et al. Rotavirus alters paracellular permeability and energy metabolism in Caco-2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 279(4), G757–766 (2000).Crossref, Medline, CAS, Google Scholar
• 45 Jacobi SK, Moeser AJ, Blikslager AT et al. Acute effects of rotavirus and malnutrition on intestinal barrier function in neonatal piglets. World J. Gastroenterol. 19(31), 5094–5102 (2013).Crossref, Medline, Google Scholar
• 46 Istrate C, Hagbom M, Vikstrom E, Magnusson KE, Svensson L. Rotavirus infection increases intestinal motility but not permeability at the onset of diarrhea. J. Virol. 88(6), 3161–3169 (2014).Crossref, Medline, Google Scholar
• 47 Sindhu KN, Sowmyanarayanan TV, Paul A et al. Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial. Clin. Infect. Dis. 58(8), 1107–1115 (2014).Crossref, Medline, CAS, Google Scholar
• 48 Han XN, Fink MP, Delude RL. Proinflammatory cytokines cause no center dot-dependent and -independent changes in expression and localization of tight junction proteins in intestinal epithelial cells. Shock 19(3), 229–237 (2003).Crossref, Medline, CAS, Google Scholar
• 49 Hietbrink F, Besselink MGH, Renooij W et al. Systemic inflammation increases intestinal permeability during experimental human endotoxemia. Shock 32(4), 374–378 (2009).Crossref, Medline, CAS, Google Scholar
• 50 O'Dwyer ST, Michie HR, Ziegler TR, Revhaug A, Smith RJ, Wilmore DW. A single dose of endotoxin increases intestinal permeability in healthy humans. Arch. Surg. 123(12), 1459–1464 (1988).Crossref, Medline, Google Scholar
• 51 Jorgensen VL, Ibsen M, Andresen L, Schulzke JD, Perner A. Effects of endotoxaemia on markers of permeability, metabolism and inflammation in the large bowel of healthy subjects. Acta Anaesthesiol. Scand. 51(8), 1085–1092 (2007).Crossref, Medline, CAS, Google Scholar
• 52 Sawa Y, Ueki T, Hata M et al. LPS-induced IL-6, IL-8, VCAM-1, and ICAM-1 expression in human lymphatic endothelium. J. Histochem. Cytochem. 56(2), 97–109 (2008).Crossref, Medline, CAS, Google Scholar
• 53 Von Der Weid P-Y, Rehal S, Ferraz JGP. Role of the lymphatic system in the pathogenesis of Crohn's disease. Curr. Opin. Gastroenterol. 27(4), 335–341 (2011).Crossref, Medline, CAS, Google Scholar
• 54 Alexander JS, Ganta VC, Jordan PA, Witte MH. Gastrointestinal lymphatics in health and disease. Pathophysiology 17(4), 315–335 (2010).Crossref, Medline, CAS, Google Scholar
• 55 Zampell JC, Elhadad S, Avraham T et al. Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury. Am. J. Physiol. Cell. Physiol. 302(4), C709–719 (2012).Crossref, Medline, CAS, Google Scholar
• 56 Pegu A, Qin S, Fallert Junecko BA, Nisato RE, Pepper MS, Reinhart TA. Human lymphatic endothelial cells express multiple functional TLRs. J. Immunol. 180(5), 3399–3405 (2008).Crossref, Medline, CAS, Google Scholar
• 57 Nemoto K, Sato H, Tanuma K, Okamura T. Mesenteric lymph flow in endotoxemic guinea pigs. Lymphat. Res. Biol. 9(3), 129–134 (2011).Crossref, Medline, CAS, Google Scholar
• 58 Amar J, Chabo C, Waget A et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of Type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol. Med. 3(9), 559–572 (2011).Crossref, Medline, CAS, Google Scholar
• 59 Harvey NL, Srinivasan RS, Dillard ME et al. Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nature Genet. 37(10), 1072–1081 (2005).Crossref, Medline, CAS, Google Scholar
• 60 Brorson H, Ohlin K, Olsson G, Nilsson M. Adipose tissue dominates chronic arm lymphedema following breast cancer: an analysis using volume rendered CT images. Lymphat. Res. Biol. 4(4), 199–210 (2006).Crossref, Medline, Google Scholar
• 61 Sawane M, Kajiya K, Kidoya H, Takagi M, Muramatsu F, Takakura N. Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity. Diabetes 62(6), 1970–1980 (2013).Crossref, Medline, CAS, Google Scholar
• 62 Zawieja SD, Wang W, Wu X, Nepiyushchikh ZV, Zawieja DC, Muthuchamy M. Impairments in the intrinsic contractility of mesenteric collecting lymphatics in a rat model of metabolic syndrome. Am. J. Physiol. Heart Circ. Physiol. 302(3), H643–653 (2012).Crossref, Medline, CAS, Google Scholar
• 63 Arngrim N, Simonsen L, Holst JJ, Bulow J. Reduced adipose tissue lymphatic drainage of macromolecules in obese subjects: a possible link between obesity and local tissue inflammation? Int. J. Obes. (Lond.) 37(5), 748–750 (2012).Crossref, Google Scholar
• 64 Harvey NL. The link between lymphatic function and adipose biology. Ann. NY Acad. Sci. 1131, 82–88 (2008).Crossref, Medline, Google Scholar
• 65 Von Der Weid PY, Rainey KJ. Review article: lymphatic system and associated adipose tissue in the development of inflammatory bowel disease. Aliment. Pharmacol. Ther. 32(6), 697–711 (2010).Crossref, Medline, Google Scholar
• 66 Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes. Rev. 11(1), 11–18 (2010).Crossref, Medline, Google Scholar
• 67 Leuwer M, Welters I, Marx G et al. Endotoxaemia leads to major increases in inflammatory adipokine gene expression in white adipose tissue of mice. Pflugers Arch. 457(4), 731–741 (2009).Crossref, Medline, CAS, Google Scholar
• 68 Mattacks CA, Sadler D, Pond CM. The cellular structure and lipid/protein composition of adipose tissue surrounding chronically stimulated lymph nodes in rats. J. Anat. 202(6), 551–561 (2003).Crossref, Medline, CAS, Google Scholar
• 69 Gummesson A, Carlsson LMS, Storlien LH et al. Intestinal permeability is associated with visceral adiposity in healthy women. Obesity 19(11), 2280–2282 (2011).Crossref, Medline, Google Scholar
• 70 Kredel LI, Batra A, Stroh T et al. Adipokines from local fat cells shape the macrophage compartment of the creeping fat in Crohn's disease. Gut 62(6), 852–862 (2012).Crossref, Medline, Google Scholar
• 71 Lam YY, Mitchell AJ, Holmes AJ et al. Role of the gut in visceral fat inflammation and metabolic disorders. Obesity (Silver Spring) 19(11), 2113–2120 (2011).Crossref, Medline, CAS, Google Scholar
• 72 Marieb EN, Katja H. Human Anatomy and Physiology: International Edition (2009).Google Scholar
• 73 Villegas R, Xiang YB, Elasy T et al. Liver enzymes, Type 2 diabetes, and metabolic syndrome in middle-aged, urban Chinese men. Metab. Synd. Rel. Disord. 9(4), 305–311 (2011).Crossref, Medline, CAS, Google Scholar
• 74 Chen P, Schnabl B. Host-microbiome interactions in alcoholic liver disease. Gut Liver 8(3), 237–241 (2014).Crossref, Medline, CAS, Google Scholar
• 75 Magalhaes I, Pingris K, Poitou C et al. Mucosal-associated invariant T cell alterations in obese and Type 2 diabetic patients. J. Clin. Invest. 125(4), 1752–1762 (2015).Crossref, Medline, Google Scholar
• 76 Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-alcoholic fatty liver disease. Dig. Dis. 28(1), 155–161 (2010).Crossref, Medline, Google Scholar
• 77 Chen SH, He F, Zhou HL, Wu HR, Xia C, Li YM. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J. Dig. Dis. 12(2), 125–130 (2011).Crossref, Medline, Google Scholar
• 78 Finelli C, Tarantino G. What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? World J. Gastroenterol. 19(6), 802–812 (2013).Crossref, Medline, Google Scholar
• 79 Baek SH, Li AH, Sassetti CM. Metabolic regulation of mycobacterial growth and antibiotic sensitivity. PLoS Biol. 9(5), e1001065 (2011).Crossref, Medline, CAS, Google Scholar
• 80 Tarantino G, Conca P, Pasanisi F et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur. J. Gastroenterol. Hepatol. 21(5), 504–511 (2009).Crossref, Medline, CAS, Google Scholar
• 81 Jiang W, Wu N, Wang X et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci. Rep. 5, 8096 (2015).Crossref, Medline, CAS, Google Scholar
• 82 Miele L, Valenza V, La Torre G et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49(6), 1877–1887 (2009).Crossref, Medline, CAS, Google Scholar
• 83 Xie YR, Liu SL, Liu X et al. Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation. Transpl. P. 43(10), 3973–3979 (2011).Crossref, Medline, CAS, Google Scholar
• 84 Chen Y, Yang F, Lu H et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54(2), 562–572 (2011).Crossref, Medline, Google Scholar
• 85 Pande C, Kumar A, Sarin SK. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol. Ther. 29(12), 1273–1281 (2009).Crossref, Medline, CAS, Google Scholar
• 86 Van Vlerken LG, Huisman EJ, Van Hoek B et al. Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability. Eur. J. Clin. Invest. 42(7), 760–767 (2012).Crossref, Medline, CAS, Google Scholar
• 87 Compare D, Coccoli P, Rocco A et al. Gut-liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr. Metab. Cardiovasc. Dis. 22(6), 471–476 (2012).Crossref, Medline, CAS, Google Scholar
• 88 Jelinek DF, Andersson S, Slaughter CA, Russell DW. Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J. Biol. Chem. 265(14), 8190–8197 (1990).Crossref, Medline, CAS, Google Scholar
• 89 Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev. 89(1), 147–191 (2009).Crossref, Medline, CAS, Google Scholar
• 90 Swann JR, Want EJ, Geier FM et al. Systemic gut microbial modulation of bile acid metabolism in host tissue compartments. Proc. Natl Acad. Sci. USA 108(Suppl. 1), 4523–4530 (2011).Crossref, Medline, CAS, Google Scholar
• 91 Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids. EMBO J. 25(7), 1419–1425 (2006).Crossref, Medline, CAS, Google Scholar
• 92 Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47(2), 241–259 (2006).Crossref, Medline, CAS, Google Scholar
• 93 Vlahcevic ZR, Stravitz RT, Heuman DM, Hylemon PB, Pandak WM. Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat. Gastroenterology 113(6), 1949–1957 (1997).Crossref, Medline, CAS, Google Scholar
• 94 Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature 489(7415), 242–249 (2012).Crossref, Medline, CAS, Google Scholar
• 95 Duboc H, Rajca S, Rainteau D et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases. Gut 62(4), 531–539 (2013).Crossref, Medline, CAS, Google Scholar
• 96 Nicholson JK, Holmes E, Kinross J et al. Host-gut microbiota metabolic interactions. Science 336(6086), 1262–1267 (2012).Crossref, Medline, CAS, Google Scholar
• 97 Fiorucci S, Mencarelli A, Palladino G, Cipriani S. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders. Trends Pharmacol. Sci. 30(11), 570–580 (2009).Crossref, Medline, CAS, Google Scholar
• 98 Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K. Targeting bile-acid signalling for metabolic diseases. Nature Rev. Drug Discov. 7(8), 678–693 (2008).Crossref, Medline, CAS, Google Scholar
• 99 Stenman LK, Holma R, Korpela R. High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids. World J. Gastroenterol. 18(9), 923–929 (2012).Crossref, Medline, CAS, Google Scholar
• 100 Suzuki T, Hara H. Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr. Metab. (Lond.) 7, 19 (2010).Crossref, Google Scholar
• 101 Yoneno K, Hisamatsu T, Shimamura K et al. TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease. Immunology 139(1), 19–29 (2013).Crossref, Medline, CAS, Google Scholar
• 102 Cipriani S, Mencarelli A, Chini MG et al. The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. PloS ONE 6(10), e25637 (2011).Crossref, Medline, CAS, Google Scholar
• 103 Duboc H, Rainteau D, Rajca S et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol. Motil. 24(6), 513–520, e246–517 (2012).Crossref, Medline, CAS, Google Scholar
• 104 Larsen N, Vogensen FK, Van Den Berg FW et al. Gut microbiota in human adults with Type 2 diabetes differs from non-diabetic adults. PloS ONE 5(2), e9085 (2010).Crossref, Medline, Google Scholar
• 105 Johnson AM, Olefsky JM. The origins and drivers of insulin resistance. Cell 152(4), 673–684 (2013).Crossref, Medline, CAS, Google Scholar
• 106 Lhoste EF, Catala I, Fiszlewicz M et al. Influence of caecal microflora and of two dietary protein levels on the adaptation of the exocrine pancreas: comparative study in germ-free and conventional rats. Br. J. Nutr. 75(3), 433–444 (1996).Crossref, Medline, CAS, Google Scholar
• 107 Cani PD, Possemiers S, Van De Wiele T et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58(8), 1091–1103 (2009).Crossref, Medline, CAS, Google Scholar
• 108 Everard A, Lazarevic V, Derrien M et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60(11), 2775–2786 (2011).Crossref, Medline, CAS, Google Scholar
• 109 Vrieze SI, Iacono WG, Mcgue M. Confluence of genes, environment, development, and behavior in a post genome-wide association study world. Dev. Psychopathol. 24(4), 1195–1214 (2012).Crossref, Medline, Google Scholar
• 110 Van Minnen LP, Blom M, Timmerman HM, Visser MR, Gooszen HG, Akkermans LM. The use of animal models to study bacterial translocation during acute pancreatitis. J. Gastrointest. Surg. 11(5), 682–689 (2007).Crossref, Medline, CAS, Google Scholar
• 111 Apte M, Pirola R, Wilson J. New insights into alcoholic pancreatitis and pancreatic cancer. J. Gastroenterol. Hepatol. 24(Suppl. 3), S51–S56 (2009).Crossref, Medline, Google Scholar
• 112 Diamant M, Blaak EE, De Vos WM. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and Type 2 diabetes? Obes. Rev. 12(4), 272–281 (2011).Crossref, Medline, CAS, Google Scholar
• 113 Qin J, Li R, Raes J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464(7285), 59–65 (2010).Crossref, Medline, CAS, Google Scholar
• 114 Amyot J, Semache M, Ferdaoussi M, Fontes G, Poitout V. Lipopolysaccharides impair insulin gene expression in isolated islets of Langerhans via Toll-like receptor-4 and NF-κB signalling. PloS ONE 7(4), e36200 (2012).Crossref, Medline, CAS, Google Scholar
• 115 Wen L, Ley RE, Volchkov PY et al. Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455(7216), 1109–1113 (2008).Crossref, Medline, CAS, Google Scholar
• 116 Neu J, Reverte CM, Mackey AD et al. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of Type 1 diabetes. J. Pediatr. Gastroenterol. Nutr. 40(5), 589–595 (2005).Crossref, Medline, Google Scholar
• 117 Bosi E, Molteni L, Radaelli MG et al. Increased intestinal permeability precedes clinical onset of Type 1 diabetes. Diabetologia 49(12), 2824–2827 (2006).Crossref, Medline, CAS, Google Scholar
• 118 Murri M, Leiva I, Gomez-Zumaquero JM et al. Gut microbiota in children with Type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. 11, 46 (2013).Crossref, Medline, Google Scholar
• 119 Heiman M, Burton JH, Deych E, Shannon WD, Greenway FL. Improved oral glucose tolerance in prediabetics and Type 2 diabetics (T2D) in a pilot clinical trial testing a novel gastrointestinal (GI) microbiome modulator. Presented at: 16th International Congress of Endocrinology & the Endocrine Society's 96th Annual Meeting & Expo. Abstract. Chicago, IL, USA (2014).Google Scholar
• 120 Greenway F, Wang S, Heiman M. A novel cobiotic containing a prebiotic and an antioxidant augments the glucose control and gastrointestinal tolerability of metformin: a case report. Beneficial Microb. 5(1), 29–32 (2014).Crossref, Medline, CAS, Google Scholar
• 121 Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444(7122), 1027–1031 (2006).Crossref, Medline, Google Scholar
• 122 Ley RE. Obesity and the human microbiome. Curr. Opin. Gastroenterol. 26(1), 5–11 (2010).Crossref, Medline, Google Scholar
• 123 Cani PD, Bibiloni R, Knauf C et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57(6), 1470–1481 (2008).Crossref, Medline, CAS, Google Scholar
• 124 Ravussin Y, Koren O, Spor A et al. Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity (Silver Spring) 20(4), 738–747 (2012).Crossref, Medline, CAS, Google Scholar
• 125 Gummesson A, Carlsson LM, Storlien LH et al. Intestinal permeability is associated with visceral adiposity in healthy women. Obesity (Silver Spring) 19(11), 2280–2282 (2011).Crossref, Medline, Google Scholar